Biocompatibility and in vivo gentamicin release from bioactive sol-gel glass implants.

Biomaterial pieces, with suitable osteogenic properties for use in the treatment of bone defects and the capability to avoid bone infections, have been synthesized. These materials are composed exclusively of gentamicin sulfate and bioactive SiO(2)-CaO-P(2)O(5) sol-gel glass (previously synthesized). Implant processing was achieved by uniaxial and isostatic pressure of the components mixture. After implanting the pieces into rabbit femur, we studied (i) the antibiotic release, determining the concentration in proximal and distal bone, liver, kidney, and lung as a function of time; and (ii) the bone growth resulting from the glass reactivity in the biologic environment. The results indicate that the implants are good carriers for local gentamicin release in the osseous tissue, exhibiting excellent biocompatibility and bone integration. Moreover, these implants are able to promote bone growth during their resorption process.

[1]  M. Vallet‐Regí,et al.  Textural properties of SiO_2 · CaO · P_2O_5 glasses prepared by the sol-gel method , 2001 .

[2]  M. Vallet‐Regí,et al.  Bioactivity in glass/PMMA composites used as drug delivery system. , 2001, Biomaterials.

[3]  María Vallet-Regí,et al.  Ceramics for medical applications , 2001 .

[4]  M. Vallet‐Regí,et al.  Gentamicin release from hydroxyapatite/poly(ethyl methacrylate)/poly(methyl methacrylate)composites. , 2000, Journal of biomedical materials research.

[5]  M. Vallet‐Regí,et al.  In vitro bioactivity and gentamicin release from glass-polymer-antibiotic composites. , 2000, Journal of biomedical materials research.

[6]  M. Vallet‐Regí,et al.  Evolution of porosity during in vitro hydroxycarbonate apatite growth in sol-gel glasses. , 2000, Journal of biomedical materials research.

[7]  P. Ducheyne Stimulation of Biological Function With Bioactive Glass , 1998 .

[8]  L. Hench,et al.  Properties of bioactive glasses and glass-ceramics , 1998 .

[9]  M. Hendriks,et al.  Tissue reactions to bacteria-inoculated rat lead samples. I. Effect of local gentamicin release through vicinal sponge or solution-dipping. , 1997, Journal of biomedical materials research.

[10]  T. Yamamuro,et al.  Drug release from a novel self-setting bioactive glass bone cement containing cephalexin and its physicochemical properties. , 1995, Journal of biomedical materials research.

[11]  L. Lidgren,et al.  Total hip joint arthroplasty with gentamicin-impregnated cement. A clinical study of gentamicin excretion kinetics. , 1983, Clinical orthopaedics and related research.

[12]  V. Vécsei,et al.  Treatment of chronic osteomyelitis by necrectomy and gentamicin-PMMA beads. , 1981, Clinical orthopaedics and related research.

[13]  M. Barza,et al.  Why Monitor Serum Levels of Gentamicin? , 1978, Clinical pharmacokinetics.

[14]  J R Pattison,et al.  Experience in Monitoring Gentamicin Therapy during Treatment of Serious Gram-Negative Sepsis , 1974, British medical journal.

[15]  H. Buchholz,et al.  [Depot effects of various antibiotics mixed with Palacos resins]. , 1970, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.